Protective-Antigen Scaffold Nanoparticle Vaccine Overcomes Carrier-Induced Suppression and Immunosenescence to Protect against Pseudomonas aeruginosa Pneumonia
ACS Nano · 2026
DOI: 10.1021/acsnano.6c04456 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Yuhang Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laborato…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Antigens, Bacterial, Nanoparticles, Immunosenescence. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Chongqing Key Project of Technology Innovation and Application Development.
Abstract (Originalsprache)
Multidrug-resistant Pseudomonas aeruginosa (PA) causes severe infections, with severe burden especially in older adults. Vaccines remain effective and are urgently needed despite immunosenescence. Self-assembling nanoparticles can enhance vaccine immunogenicity, but their translational use is constrained by the useless anticarrier immunity and carrier-induced epitope suppression (CIES). Herein, we developed a protective-antigen-based nanoparticle platform in which the PA chaperonin GroEL, an intrinsically self-assembling protective antigen, serves as the scaffold for a fusion immunogen reGroEL-PO, which displays the PcrV-OprI antigen (rePO). In mice, pre-existing anti-GroEL immunity did not blunt responses but enhanced anti-rePO immunity. Mechanistically, reGroEL-PO increased antigen uptake by antigen-presenting cells, promoted dendritic-cell maturation and accelerated both humoral and cellular immunity. In addition, reGroEL-PO elicited immune responses and conferred protection in adult and aged mice. These data demonstrate reGroEL-PO as a PA vaccine candidate and illustrate a nanoparticle design that leverages protective carriers and circumvents CIES effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Army Medical University;Chongqing400038, china.
- Hubei Province Xuanen No.1 High School, Hubei445500, China.
- Chongqing Yuanlun Biopharmaceuticals Inc, Chongqing400037, China.
- 953rd Hospital, Xinqiao Hospital, Army Medical University, Shigatse857000, China.
- Department of Respiratory and Critical Care Medicine, Xinqiao Hospital, Army Medical University, Chongqing400037, China.
- Clinical Medical Research Center, Southwest Hospital, Army Medical University, Chongqing400038, China.
ORCID-Profile: Jiang Gu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chongqing Key Project of Technology Innovation and Application Development
- Postdoctoral Fellowship Program of CPSF
Zitieren
APA
Li, Y., Zhao, H., Wu, M., Zeng, S., Zhang, Y., Xia, H., Li, J., Cheng, X., Wan, J., Zhu, Z., Zhang, Y., Wang, Y., Liu, X., Liao, Y., Cui, H., Yang, F., Zhang, Y., Zou, Q., & Gu, J. (2026). Protective-Antigen Scaffold Nanoparticle Vaccine Overcomes Carrier-Induced Suppression and Immunosenescence to Protect against Pseudomonas aeruginosa Pneumonia. ACS Nano. https://doi.org/10.1021/acsnano.6c04456
Vancouver
Li Y, Zhao H, Wu M, Zeng S, Zhang Y, Xia H, et al. Protective-Antigen Scaffold Nanoparticle Vaccine Overcomes Carrier-Induced Suppression and Immunosenescence to Protect against Pseudomonas aeruginosa Pneumonia. ACS Nano. 2026. doi:10.1021/acsnano.6c04456
BibTeX
@article{Li2026,
author = {Li, Yuhang and Zhao, Hui and Wu, Meilin and Zeng, Sheng and Zhang, Yueyue and Xia, Huan and Li, Junyi and Cheng, Xin and Wan, Jiqing and Zhu, Zifan and Zhang, Yi and Wang, Ying and Liu, Xinglong and Liao, Yaling and Cui, Hongrong and Yang, Feng and Zhang, Yajuan and Zou, Quanming and Gu, Jiang},
title = {Protective-Antigen Scaffold Nanoparticle Vaccine Overcomes Carrier-Induced Suppression and Immunosenescence to Protect against Pseudomonas aeruginosa Pneumonia},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c04456}
}
EUVIMED